Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early‐onset Parkinson's Disease

Identifieur interne : 001225 ( Main/Corpus ); précédent : 001224; suivant : 001226

Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early‐onset Parkinson's Disease

Auteurs : J. M. Hertz ; K. Stergaard ; I. Juncker ; S. Pedersen ; A. Romstad ; L. B. M Ller ; F. Güttler ; E. Dupont

Source :

RBID : ISTEX:C8DCBFA33A495869098FC96C2D78E7BE1690643D

English descriptors

Abstract

Autosomal recessive Parkinson's disease (PD) with early‐onset may be caused by mutations in the parkin gene (PARK2). We have ascertained 87 Danish patients with an early‐onset form of PD (age at onset ≤40 years, or ≤50 years if family history is positive) in a multicenter study in order to determine the frequency of PARK2 mutations. Analysis of the GTP cyclohydrolase I gene (GCH1) and the tyrosine hydroxylase gene (TH), mutated in dopa‐responsive dystonia and juvenile PD, have also been included. Ten different PARK2 mutations were identified in 10 patients. Two of the patients (2.3%) were found to have homozygous or compound heterozygous mutations, and eight of the patients (9.2%) were found to be heterozygous. A mutation has been identified in 10.4% of the sporadic cases and in 15.0% of cases with a positive family history of PD. One patient was found to be heterozygous for both a PARK2 mutation and a missense mutation (A6T) in TH of unknown significance. It cannot be excluded that both mutations contribute to the phenotype. No other putative disease causing TH or GCH1 mutations were found. In conclusion, homozygous, or compound heterozygous PARK2 mutations, and mutations in GCH1 and TH, are rare even in a population of PD patients with early‐onset of the disease.

Url:
DOI: 10.1111/j.1468-1331.2006.01249.x

Links to Exploration step

ISTEX:C8DCBFA33A495869098FC96C2D78E7BE1690643D

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early‐onset Parkinson's Disease</title>
<author>
<name sortKey="Hertz, J M" sort="Hertz, J M" uniqKey="Hertz J" first="J. M." last="Hertz">J. M. Hertz</name>
<affiliation>
<mods:affiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey=" Stergaard, K" sort=" Stergaard, K" uniqKey=" Stergaard K" first="K." last=" Stergaard">K. Stergaard</name>
<affiliation>
<mods:affiliation>Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Juncker, I" sort="Juncker, I" uniqKey="Juncker I" first="I." last="Juncker">I. Juncker</name>
<affiliation>
<mods:affiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pedersen, S" sort="Pedersen, S" uniqKey="Pedersen S" first="S." last="Pedersen">S. Pedersen</name>
<affiliation>
<mods:affiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Romstad, A" sort="Romstad, A" uniqKey="Romstad A" first="A." last="Romstad">A. Romstad</name>
<affiliation>
<mods:affiliation>The John F. Kennedy Institute, Glostrup, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="M Ller, L B" sort="M Ller, L B" uniqKey="M Ller L" first="L. B." last="M Ller">L. B. M Ller</name>
<affiliation>
<mods:affiliation>The John F. Kennedy Institute, Glostrup, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Guttler, F" sort="Guttler, F" uniqKey="Guttler F" first="F." last="Güttler">F. Güttler</name>
<affiliation>
<mods:affiliation>The John F. Kennedy Institute, Glostrup, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dupont, E" sort="Dupont, E" uniqKey="Dupont E" first="E." last="Dupont">E. Dupont</name>
<affiliation>
<mods:affiliation>Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C8DCBFA33A495869098FC96C2D78E7BE1690643D</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1111/j.1468-1331.2006.01249.x</idno>
<idno type="url">https://api.istex.fr/document/C8DCBFA33A495869098FC96C2D78E7BE1690643D/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001225</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early‐onset Parkinson's Disease</title>
<author>
<name sortKey="Hertz, J M" sort="Hertz, J M" uniqKey="Hertz J" first="J. M." last="Hertz">J. M. Hertz</name>
<affiliation>
<mods:affiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey=" Stergaard, K" sort=" Stergaard, K" uniqKey=" Stergaard K" first="K." last=" Stergaard">K. Stergaard</name>
<affiliation>
<mods:affiliation>Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Juncker, I" sort="Juncker, I" uniqKey="Juncker I" first="I." last="Juncker">I. Juncker</name>
<affiliation>
<mods:affiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Pedersen, S" sort="Pedersen, S" uniqKey="Pedersen S" first="S." last="Pedersen">S. Pedersen</name>
<affiliation>
<mods:affiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Romstad, A" sort="Romstad, A" uniqKey="Romstad A" first="A." last="Romstad">A. Romstad</name>
<affiliation>
<mods:affiliation>The John F. Kennedy Institute, Glostrup, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="M Ller, L B" sort="M Ller, L B" uniqKey="M Ller L" first="L. B." last="M Ller">L. B. M Ller</name>
<affiliation>
<mods:affiliation>The John F. Kennedy Institute, Glostrup, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Guttler, F" sort="Guttler, F" uniqKey="Guttler F" first="F." last="Güttler">F. Güttler</name>
<affiliation>
<mods:affiliation>The John F. Kennedy Institute, Glostrup, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dupont, E" sort="Dupont, E" uniqKey="Dupont E" first="E." last="Dupont">E. Dupont</name>
<affiliation>
<mods:affiliation>Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">European Journal of Neurology</title>
<idno type="ISSN">1351-5101</idno>
<idno type="eISSN">1468-1331</idno>
<imprint>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2006-04">2006-04</date>
<biblScope unit="volume">13</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="385">385</biblScope>
<biblScope unit="page" to="390">390</biblScope>
</imprint>
<idno type="ISSN">1351-5101</idno>
</series>
<idno type="istex">C8DCBFA33A495869098FC96C2D78E7BE1690643D</idno>
<idno type="DOI">10.1111/j.1468-1331.2006.01249.x</idno>
<idno type="ArticleID">ENE1249</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1351-5101</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>GCH1</term>
<term>PARK2</term>
<term>Parkin</term>
<term>Parkinson's disease</term>
<term>TH</term>
<term>early‐onset</term>
<term>mutation analysis</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Autosomal recessive Parkinson's disease (PD) with early‐onset may be caused by mutations in the parkin gene (PARK2). We have ascertained 87 Danish patients with an early‐onset form of PD (age at onset ≤40 years, or ≤50 years if family history is positive) in a multicenter study in order to determine the frequency of PARK2 mutations. Analysis of the GTP cyclohydrolase I gene (GCH1) and the tyrosine hydroxylase gene (TH), mutated in dopa‐responsive dystonia and juvenile PD, have also been included. Ten different PARK2 mutations were identified in 10 patients. Two of the patients (2.3%) were found to have homozygous or compound heterozygous mutations, and eight of the patients (9.2%) were found to be heterozygous. A mutation has been identified in 10.4% of the sporadic cases and in 15.0% of cases with a positive family history of PD. One patient was found to be heterozygous for both a PARK2 mutation and a missense mutation (A6T) in TH of unknown significance. It cannot be excluded that both mutations contribute to the phenotype. No other putative disease causing TH or GCH1 mutations were found. In conclusion, homozygous, or compound heterozygous PARK2 mutations, and mutations in GCH1 and TH, are rare even in a population of PD patients with early‐onset of the disease.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>J. M. Hertz</name>
<affiliations>
<json:string>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>K. Østergaard</name>
<affiliations>
<json:string>Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>I. Juncker</name>
<affiliations>
<json:string>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>S. Pedersen</name>
<affiliations>
<json:string>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>A. Romstad</name>
<affiliations>
<json:string>The John F. Kennedy Institute, Glostrup, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>L. B. Møller</name>
<affiliations>
<json:string>The John F. Kennedy Institute, Glostrup, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>F. Güttler</name>
<affiliations>
<json:string>The John F. Kennedy Institute, Glostrup, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>E. Dupont</name>
<affiliations>
<json:string>Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>early‐onset</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>GCH1</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>mutation analysis</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PARK2</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Parkin</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Parkinson's disease</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>TH</value>
</json:item>
</subject>
<articleId>
<json:string>ENE1249</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<abstract>Autosomal recessive Parkinson's disease (PD) with early‐onset may be caused by mutations in the parkin gene (PARK2). We have ascertained 87 Danish patients with an early‐onset form of PD (age at onset ≤40 years, or ≤50 years if family history is positive) in a multicenter study in order to determine the frequency of PARK2 mutations. Analysis of the GTP cyclohydrolase I gene (GCH1) and the tyrosine hydroxylase gene (TH), mutated in dopa‐responsive dystonia and juvenile PD, have also been included. Ten different PARK2 mutations were identified in 10 patients. Two of the patients (2.3%) were found to have homozygous or compound heterozygous mutations, and eight of the patients (9.2%) were found to be heterozygous. A mutation has been identified in 10.4% of the sporadic cases and in 15.0% of cases with a positive family history of PD. One patient was found to be heterozygous for both a PARK2 mutation and a missense mutation (A6T) in TH of unknown significance. It cannot be excluded that both mutations contribute to the phenotype. No other putative disease causing TH or GCH1 mutations were found. In conclusion, homozygous, or compound heterozygous PARK2 mutations, and mutations in GCH1 and TH, are rare even in a population of PD patients with early‐onset of the disease.</abstract>
<qualityIndicators>
<score>6.456</score>
<pdfVersion>1.4</pdfVersion>
<pdfPageSize>595 x 782 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>7</keywordCount>
<abstractCharCount>1285</abstractCharCount>
<pdfWordCount>3472</pdfWordCount>
<pdfCharCount>22051</pdfCharCount>
<pdfPageCount>6</pdfPageCount>
<abstractWordCount>207</abstractWordCount>
</qualityIndicators>
<title>Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early‐onset Parkinson's Disease</title>
<genre>
<json:string>article</json:string>
</genre>
<host>
<volume>13</volume>
<publisherId>
<json:string>ENE</json:string>
</publisherId>
<pages>
<total>6</total>
<last>390</last>
<first>385</first>
</pages>
<issn>
<json:string>1351-5101</json:string>
</issn>
<issue>4</issue>
<genre>
<json:string>Journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1468-1331</json:string>
</eissn>
<title>European Journal of Neurology</title>
<doi>
<json:string>10.1111/(ISSN)1468-1331</json:string>
</doi>
</host>
<publicationDate>2006</publicationDate>
<copyrightDate>2006</copyrightDate>
<doi>
<json:string>10.1111/j.1468-1331.2006.01249.x</json:string>
</doi>
<id>C8DCBFA33A495869098FC96C2D78E7BE1690643D</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/C8DCBFA33A495869098FC96C2D78E7BE1690643D/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/C8DCBFA33A495869098FC96C2D78E7BE1690643D/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/C8DCBFA33A495869098FC96C2D78E7BE1690643D/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early‐onset Parkinson's Disease</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<availability>
<p>WILEY</p>
</availability>
<date>2006</date>
</publicationStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early‐onset Parkinson's Disease</title>
<author>
<persName>
<forename type="first">J. M.</forename>
<surname>Hertz</surname>
</persName>
<affiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</affiliation>
</author>
<author>
<persName>
<forename type="first">K.</forename>
<surname>Østergaard</surname>
</persName>
<affiliation>Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark</affiliation>
</author>
<author>
<persName>
<forename type="first">I.</forename>
<surname>Juncker</surname>
</persName>
<affiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</affiliation>
</author>
<author>
<persName>
<forename type="first">S.</forename>
<surname>Pedersen</surname>
</persName>
<affiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</affiliation>
</author>
<author>
<persName>
<forename type="first">A.</forename>
<surname>Romstad</surname>
</persName>
<affiliation>The John F. Kennedy Institute, Glostrup, Denmark</affiliation>
</author>
<author>
<persName>
<forename type="first">L. B.</forename>
<surname>Møller</surname>
</persName>
<affiliation>The John F. Kennedy Institute, Glostrup, Denmark</affiliation>
</author>
<author>
<persName>
<forename type="first">F.</forename>
<surname>Güttler</surname>
</persName>
<affiliation>The John F. Kennedy Institute, Glostrup, Denmark</affiliation>
</author>
<author>
<persName>
<forename type="first">E.</forename>
<surname>Dupont</surname>
</persName>
<affiliation>Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark</affiliation>
</author>
</analytic>
<monogr>
<title level="j">European Journal of Neurology</title>
<idno type="pISSN">1351-5101</idno>
<idno type="eISSN">1468-1331</idno>
<idno type="DOI">10.1111/(ISSN)1468-1331</idno>
<imprint>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2006-04"></date>
<biblScope unit="volume">13</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="385">385</biblScope>
<biblScope unit="page" to="390">390</biblScope>
</imprint>
</monogr>
<idno type="istex">C8DCBFA33A495869098FC96C2D78E7BE1690643D</idno>
<idno type="DOI">10.1111/j.1468-1331.2006.01249.x</idno>
<idno type="ArticleID">ENE1249</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2006</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>Autosomal recessive Parkinson's disease (PD) with early‐onset may be caused by mutations in the parkin gene (PARK2). We have ascertained 87 Danish patients with an early‐onset form of PD (age at onset ≤40 years, or ≤50 years if family history is positive) in a multicenter study in order to determine the frequency of PARK2 mutations. Analysis of the GTP cyclohydrolase I gene (GCH1) and the tyrosine hydroxylase gene (TH), mutated in dopa‐responsive dystonia and juvenile PD, have also been included. Ten different PARK2 mutations were identified in 10 patients. Two of the patients (2.3%) were found to have homozygous or compound heterozygous mutations, and eight of the patients (9.2%) were found to be heterozygous. A mutation has been identified in 10.4% of the sporadic cases and in 15.0% of cases with a positive family history of PD. One patient was found to be heterozygous for both a PARK2 mutation and a missense mutation (A6T) in TH of unknown significance. It cannot be excluded that both mutations contribute to the phenotype. No other putative disease causing TH or GCH1 mutations were found. In conclusion, homozygous, or compound heterozygous PARK2 mutations, and mutations in GCH1 and TH, are rare even in a population of PD patients with early‐onset of the disease.</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>early‐onset</term>
</item>
<item>
<term>GCH1</term>
</item>
<item>
<term>mutation analysis</term>
</item>
<item>
<term>PARK2</term>
</item>
<item>
<term>Parkin</term>
</item>
<item>
<term>Parkinson's disease</term>
</item>
<item>
<term>TH</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2006-04">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/C8DCBFA33A495869098FC96C2D78E7BE1690643D/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Blackwell Publishing Ltd</publisherName>
<publisherLoc>Oxford, UK</publisherLoc>
</publisherInfo>
<doi origin="wiley" registered="yes">10.1111/(ISSN)1468-1331</doi>
<issn type="print">1351-5101</issn>
<issn type="electronic">1468-1331</issn>
<idGroup>
<id type="product" value="ENE"></id>
<id type="publisherDivision" value="ST"></id>
</idGroup>
<titleGroup>
<title type="main" sort="EUROPEAN JOURNAL OF NEUROLOGY">European Journal of Neurology</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="04004">
<doi origin="wiley">10.1111/ene.2006.13.issue-4</doi>
<numberingGroup>
<numbering type="journalVolume" number="13">13</numbering>
<numbering type="journalIssue" number="4">4</numbering>
</numberingGroup>
<coverDate startDate="2006-04">April 2006</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="10" status="forIssue">
<doi origin="wiley">10.1111/j.1468-1331.2006.01249.x</doi>
<idGroup>
<id type="unit" value="ENE1249"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="6"></count>
</countGroup>
<titleGroup>
<title type="tocHeading1">Original Articles</title>
</titleGroup>
<eventGroup>
<event type="firstOnline" date="2006-04-21"></event>
<event type="publishedOnlineFinalForm" date="2006-04-21"></event>
<event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-06"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-24"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-16"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst" number="385">385</numbering>
<numbering type="pageLast" number="390">390</numbering>
</numberingGroup>
<correspondenceTo>Jens Michael Hertz, Department of Clinical Genetics, Aarhus University Hospital, The Bartholin Building, DK‐8000 Aarhus C, Denmark (tel.: +45 89 49 43 65; fax: +45 89 49 43 70; e‐mail:
<email>jmher@as.aaa.dk</email>
).</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:ENE.ENE1249.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<unparsedEditorialHistory>Received 31 January 2005 Accepted 26 April 2005</unparsedEditorialHistory>
<countGroup>
<count type="figureTotal" number="0"></count>
<count type="tableTotal" number="1"></count>
</countGroup>
<titleGroup>
<title type="main">Low frequency of
<i>Parkin</i>
,
<i>Tyrosine Hydroxylase</i>
, and
<i>GTP Cyclohydrolase I</i>
gene mutations in a Danish population of early‐onset Parkinson's Disease</title>
<title type="shortAuthors">J. M. Hertz
<i>et al</i>
.</title>
<title type="short">Low frequency of PARK2, GCH1, and TH mutations</title>
</titleGroup>
<creators>
<creator creatorRole="author" xml:id="cr1" affiliationRef="#a1">
<personName>
<givenNames>J. M.</givenNames>
<familyName>Hertz</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr2" affiliationRef="#a2">
<personName>
<givenNames>K.</givenNames>
<familyName>Østergaard</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr3" affiliationRef="#a1">
<personName>
<givenNames>I.</givenNames>
<familyName>Juncker</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr4" affiliationRef="#a1">
<personName>
<givenNames>S.</givenNames>
<familyName>Pedersen</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr5" affiliationRef="#a3">
<personName>
<givenNames>A.</givenNames>
<familyName>Romstad</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr6" affiliationRef="#a3">
<personName>
<givenNames>L. B.</givenNames>
<familyName>Møller</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr7" affiliationRef="#a3">
<personName>
<givenNames>F.</givenNames>
<familyName>Güttler</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr8" affiliationRef="#a2">
<personName>
<givenNames>E.</givenNames>
<familyName>Dupont</familyName>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="a1" countryCode="DK">
<unparsedAffiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</unparsedAffiliation>
</affiliation>
<affiliation xml:id="a2" countryCode="DK">
<unparsedAffiliation>Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark</unparsedAffiliation>
</affiliation>
<affiliation xml:id="a3" countryCode="DK">
<unparsedAffiliation>The John F. Kennedy Institute, Glostrup, Denmark</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en">
<keyword xml:id="k1">early‐onset</keyword>
<keyword xml:id="k2">
<i>GCH1</i>
</keyword>
<keyword xml:id="k3">mutation analysis</keyword>
<keyword xml:id="k4">
<i>PARK2</i>
</keyword>
<keyword xml:id="k5">
<i>Parkin</i>
</keyword>
<keyword xml:id="k6">Parkinson's disease</keyword>
<keyword xml:id="k7">
<i>TH</i>
</keyword>
</keywordGroup>
<abstractGroup>
<abstract type="main" xml:lang="en">
<p>Autosomal recessive Parkinson's disease (PD) with early‐onset may be caused by mutations in the
<i>parkin</i>
gene (
<i>PARK2</i>
). We have ascertained 87 Danish patients with an early‐onset form of PD (age at onset ≤40 years, or ≤50 years if family history is positive) in a multicenter study in order to determine the frequency of
<i>PARK2</i>
mutations. Analysis of the
<i>GTP cyclohydrolase I</i>
gene (
<i>GCH1</i>
) and the
<i>tyrosine hydroxylase</i>
gene (
<i>TH</i>
), mutated in dopa‐responsive dystonia and juvenile PD, have also been included. Ten different
<i>PARK2</i>
mutations were identified in 10 patients. Two of the patients (2.3%) were found to have homozygous or compound heterozygous mutations, and eight of the patients (9.2%) were found to be heterozygous. A mutation has been identified in 10.4% of the sporadic cases and in 15.0% of cases with a positive family history of PD. One patient was found to be heterozygous for both a
<i>PARK2</i>
mutation and a missense mutation (A6T) in
<i>TH</i>
of unknown significance. It cannot be excluded that both mutations contribute to the phenotype. No other putative disease causing
<i>TH</i>
or
<i>GCH1</i>
mutations were found. In conclusion, homozygous, or compound heterozygous
<i>PARK2</i>
mutations, and mutations in
<i>GCH1</i>
and
<i>TH</i>
, are rare even in a population of PD patients with early‐onset of the disease.</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early‐onset Parkinson's Disease</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Low frequency of PARK2, GCH1, and TH mutations</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Low frequency of</title>
</titleInfo>
<name type="personal">
<namePart type="given">J. M.</namePart>
<namePart type="family">Hertz</namePart>
<affiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">K.</namePart>
<namePart type="family">Østergaard</namePart>
<affiliation>Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">I.</namePart>
<namePart type="family">Juncker</namePart>
<affiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S.</namePart>
<namePart type="family">Pedersen</namePart>
<affiliation>Department of Clinical Genetics, Aarhus University Hospital, Aarhus C, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A.</namePart>
<namePart type="family">Romstad</namePart>
<affiliation>The John F. Kennedy Institute, Glostrup, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">L. B.</namePart>
<namePart type="family">Møller</namePart>
<affiliation>The John F. Kennedy Institute, Glostrup, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">F.</namePart>
<namePart type="family">Güttler</namePart>
<affiliation>The John F. Kennedy Institute, Glostrup, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">E.</namePart>
<namePart type="family">Dupont</namePart>
<affiliation>Department of Neurology, Aarhus University Hospital, Aarhus C, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo>
<publisher>Blackwell Publishing Ltd</publisher>
<place>
<placeTerm type="text">Oxford, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2006-04</dateIssued>
<edition>Received 31 January 2005 Accepted 26 April 2005</edition>
<copyrightDate encoding="w3cdtf">2006</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="tables">1</extent>
</physicalDescription>
<abstract lang="en">Autosomal recessive Parkinson's disease (PD) with early‐onset may be caused by mutations in the parkin gene (PARK2). We have ascertained 87 Danish patients with an early‐onset form of PD (age at onset ≤40 years, or ≤50 years if family history is positive) in a multicenter study in order to determine the frequency of PARK2 mutations. Analysis of the GTP cyclohydrolase I gene (GCH1) and the tyrosine hydroxylase gene (TH), mutated in dopa‐responsive dystonia and juvenile PD, have also been included. Ten different PARK2 mutations were identified in 10 patients. Two of the patients (2.3%) were found to have homozygous or compound heterozygous mutations, and eight of the patients (9.2%) were found to be heterozygous. A mutation has been identified in 10.4% of the sporadic cases and in 15.0% of cases with a positive family history of PD. One patient was found to be heterozygous for both a PARK2 mutation and a missense mutation (A6T) in TH of unknown significance. It cannot be excluded that both mutations contribute to the phenotype. No other putative disease causing TH or GCH1 mutations were found. In conclusion, homozygous, or compound heterozygous PARK2 mutations, and mutations in GCH1 and TH, are rare even in a population of PD patients with early‐onset of the disease.</abstract>
<subject lang="en">
<genre>Keywords</genre>
<topic>early‐onset</topic>
<topic>GCH1</topic>
<topic>mutation analysis</topic>
<topic>PARK2</topic>
<topic>Parkin</topic>
<topic>Parkinson's disease</topic>
<topic>TH</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>European Journal of Neurology</title>
</titleInfo>
<genre type="Journal">journal</genre>
<identifier type="ISSN">1351-5101</identifier>
<identifier type="eISSN">1468-1331</identifier>
<identifier type="DOI">10.1111/(ISSN)1468-1331</identifier>
<identifier type="PublisherID">ENE</identifier>
<part>
<date>2006</date>
<detail type="volume">
<caption>vol.</caption>
<number>13</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>4</number>
</detail>
<extent unit="pages">
<start>385</start>
<end>390</end>
<total>6</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">C8DCBFA33A495869098FC96C2D78E7BE1690643D</identifier>
<identifier type="DOI">10.1111/j.1468-1331.2006.01249.x</identifier>
<identifier type="ArticleID">ENE1249</identifier>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Blackwell Publishing Ltd</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001225 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001225 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:C8DCBFA33A495869098FC96C2D78E7BE1690643D
   |texte=   Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early‐onset Parkinson's Disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024